Midazolam, Ketamine, and Propofol: While We Slept, Others Worked on Anesthetizing Infusions for Refractory Status Epilepticus
- PMID: 37662457
- PMCID: PMC10470094
- DOI: 10.1177/15357597231171240
Midazolam, Ketamine, and Propofol: While We Slept, Others Worked on Anesthetizing Infusions for Refractory Status Epilepticus
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Comment on
-
Management of Refractory Status Epilepticus: An International Cohort Study (MORSE CODe) Analysis of Patients Managed in the ICU.Neurology. 2022 Sep 13;99(11):e1191-e1201. doi: 10.1212/WNL.0000000000200818. Epub 2022 Aug 2. Neurology. 2022. PMID: 35918156 Free PMC article.
References
-
- Buratti S, Giacheri E, Palmieri A, et al. Ketamine as advanced second-line treatment in benzodiazepine-refractory convulsive status epilepticus in children. Epilepsia. 2023;doi:10.1111/epi.17550 - PubMed
-
- Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51(2):251–256. doi:10.1111/j.1528-1167.2009.02323.x - PubMed
-
- Mundlamuri RC, Sinha S, Subbakrishna DK, et al. Management of generalised convulsive status epilepticus (SE): a prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam—Pilot study. Epilepsy Res. 2015;114:52–58. doi:10.1016/j.eplepsyres.2015.04.013 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
